Geron
GERN
231 hedge funds and large institutions have $1.43B invested in Geron in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 66 increasing their positions, 64 reducing their positions, and 22 closing their positions.
181% more call options, than puts
Call options by funds: $15.7M | Put options by funds: $5.59M
145% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 22
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
68% more capital invested
Capital invested by funds: $852M → $1.43B (+$580M)
14% more funds holding
Funds holding: 202 → 231 (+29)
5.08% more ownership
Funds ownership: 74.38% → 79.47% (+5.1%)
3% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 64
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$27.8M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$20.2M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$16.8M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$16.1M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$14.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$39.8M |
| 2 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$22.4M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$18.6M |
| 4 |
Millennium Management
New York
|
-$16.6M |
| 5 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$13.4M |
GERN Hedge Fund Activity: Q1 2024 in Review
231 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Geron (GERN) for Q1 2024, worth a combined $1.43B — up 68% from $852M a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new GERN positions and 22 closed out — a net gain of 32 holders — while 66 added to existing stakes and 64 trimmed.
The largest buyer was OrbiMed, adding an estimated $27.8M. The largest seller was Morgan Stanley, cutting an estimated $39.8M.
- 231 institutional investors held Geron (GERN) as of Q1 2024, up from 202 in Q4 2023.
- Funds reported $1.43B of Geron stock for Q1 2024, up 68% quarter-over-quarter.
- 54 funds opened new Geron positions in Q1 2024 and 22 closed out, a net change of +32 holders.
- The largest Geron buyer in Q1 2024 was OrbiMed, an estimated $27.8M added.
- The largest Geron seller in Q1 2024 was Morgan Stanley, an estimated $39.8M sold.
Based on aggregated 13F filings for Q1 2024.